Your browser doesn't support javascript.
loading
SUSCEPTIBILITY OF Candida spp. ISOLATED FROM BLOOD CULTURES AS EVALUATED USING THE M27-A3 AND NEW M27-S4 APPROVED BREAKPOINTS / Suscetibilidade de Candida spp. isoladas de hemocultivos, avaliadas pelos breakpoints dos documentos M27-A3 e M27-S4 do CLSI
Santos, Edileusa Rosa dos; Forno, Camila F. Dal; Hernandez, Mari Glei; Kubiça, Thaís Felli; Venturini, Tarcieli P.; Chassot, Francieli; Santurio, Janio M.; Alves, Sydney Hartz.
  • Santos, Edileusa Rosa dos; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Forno, Camila F. Dal; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Hernandez, Mari Glei; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Kubiça, Thaís Felli; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Venturini, Tarcieli P.; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Chassot, Francieli; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Santurio, Janio M.; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
  • Alves, Sydney Hartz; Federal University of Santa Maria. Health Science Center. Post-Graduate Program in Pharmaceutical Sciences. Santa Maria. BR
Rev. Inst. Med. Trop. Säo Paulo ; 56(6): 477-482, Nov-Dec/2014. tab
Article in English | LILACS | ID: lil-725802
ABSTRACT
The high mortality rates associated with candidemia episodes and the emergence of resistance to antifungal agents necessitate the monitoring of the susceptibility of fungal isolates to antifungal treatments. The new, recently approved, species-specific clinical breakpoints (SS-CBPs)(M27-S4) for evaluating susceptibility require careful interpretation and comparison with the former proposals made using the M27-A3 breakpoints, both from CLSI. This study evaluated the susceptibility of the different species of Candida that were isolated from candidemias based on these two clinical breakpoints. Four hundred and twenty-two isolates were identified and, among them, C. parapsilosis comprised 46.68%, followed by C. albicans (35.78%), C. tropicalis (9.71%), C. glabrata (3.55%), C. lusitaniae (1.65%), C. guilliermondii (1.65%) and C. krusei (0.94%). In accordance with the M27-A3 criteria, 33 (7.81%) non-susceptible isolates were identified, of which 16 (3.79%) were resistant to antifungal agents. According to SS-CBPs, 80 (18.95%) isolates were non-susceptible, and 10 (2.36%) of these were drug resistant. When the total number of non-susceptible isolates was considered, the new SS-CBPs detected 2.4 times the number of isolates that were detected using the M27-A3 interpretative criteria. In conclusion, the detection of an elevated number of non-susceptible species has highlighted the relevance of evaluating susceptibility tests using new, species-specific clinical breakpoints (SS-CBPs), which could impact the profile of non-susceptible Candida spp. to antifungal agents that require continuous susceptibility monitoring.
RESUMO
As elevadas taxas de mortalidade associadas com episódios de candidemia e a emergência da resistência aos antifúngicos, requerem o monitoramento da suscetibilidade de Candida spp., isoladas das candidemias, frente aos agentes antifúngicos. Os novos breakpoints, chamados “espécie-específicos,” foram recentemente aprovados (M27-S4) requerendo, pois, cuidadosa interpretação e comparações com aqueles até agora utilizados (M27-A3); ambos são propostos pelo Clinical Laboratory Standard Institute (CLSI). O presente estudo avaliou a suscetibilidade de espécies de Candida isoladas de candidemias baseando-se nestes dois breakpoints. Quatrocentos e vinte e dois isolados de Candida foram identificados e assim distribuídos C. parapsilosis (48,68%), C. albicans (35,78%), C. tropicalis (9,71%), C. glabrata (3,55%), C. lusitaniae (1,65%), C. guilliermondii (1,65%), C. krusei (0,94%). Com base nos critérios do M27-A3, um total de 33 (7,81%) isolados foram julgados não-sensíveis, dos quais 16 (3,79%) como resistentes aos antifúngicos. De acordo com os breakpoints espécie-específicos (M27-S4) um total de 80 (18,95%) isolados foram considerados não-sensíveis, dos quais 10 (2,36%) resistentes a algum dos antifúngicos testados. Com base nos novos breakpoints espécie-específicos, o número de isolados não-sensíveis foi 2,4 vezes maior do que o número de não-sensíveis detectado pelos breakpoints do documento M27-A3. A detecção de um elevado número de isolados não-sensíveis através dos breakpoints propostos pelo M27-S4 destaca a importância dos testes de suscetibilidade, os quais trarão impactos no reconhecimento de isolados de Candida spp. não-sensíveis em episódios de candidemias, requerendo, portanto, continua avaliação.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Candida / Microbial Sensitivity Tests / Antifungal Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Rev. Inst. Med. Trop. Säo Paulo Journal subject: Tropical Medicine Year: 2014 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of Santa Maria/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Candida / Microbial Sensitivity Tests / Antifungal Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Rev. Inst. Med. Trop. Säo Paulo Journal subject: Tropical Medicine Year: 2014 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of Santa Maria/BR